Actinomycin D: The Role of Actinomycin D in Targeted Cancer Therapy | GlpBio
- last year
Actinomycin D is a type of antibiotic that is produced by certain types of bacteria. It is a polypeptide that is composed of a chain of amino acids and is classified as an antitumor antibiotic.
Actinomycin D works by inhibiting the synthesis of DNA, which is the genetic material that carries the instructions for the synthesis of proteins. This makes it effective at inhibiting the growth of certain types of cancer cells, as well as other types of cells that divide rapidly, such as bacteria and fungi.
The Role of Actinomycin D in Targeted Cancer Therapy involves its ability to specifically target and inhibit the activity of cancer cells, making it a valuable tool in precision medicine.
Actinomycin D is typically used in combination with other chemotherapy drugs to treat a variety of types of cancer, including sarcomas, lymphomas, and leukemias. It is also used in research to study the role of DNA in the development and function of cells.
For details please check: https://www.glpbio.com/actinomycin-d.html
Actinomycin D works by inhibiting the synthesis of DNA, which is the genetic material that carries the instructions for the synthesis of proteins. This makes it effective at inhibiting the growth of certain types of cancer cells, as well as other types of cells that divide rapidly, such as bacteria and fungi.
The Role of Actinomycin D in Targeted Cancer Therapy involves its ability to specifically target and inhibit the activity of cancer cells, making it a valuable tool in precision medicine.
Actinomycin D is typically used in combination with other chemotherapy drugs to treat a variety of types of cancer, including sarcomas, lymphomas, and leukemias. It is also used in research to study the role of DNA in the development and function of cells.
For details please check: https://www.glpbio.com/actinomycin-d.html